Preventing Early Childhood Caries With a Silver Diamine Fluoride Gel

March 3, 2026 updated by: Chun Hung Chu, The University of Hong Kong

Randomized Clinical Trial to Prevent Early Childhood Caries With a Silver Diamine Fluoride Gel

The objective is to compare the efficacy of SDF gel with that of NaF varnish in preventing carious lesions in preschool children when applied at half-yearly intervals over a 24-month period.

Study Overview

Status

Active, not recruiting

Detailed Description

Aim: The World Health Organization (WHO) included SDF in the WHO Model List of Essential Medicines. SDF is typically available as a 38% aqueous solution, which is runny and difficult to apply. A 38% SDF gel has been introduced but it has not been tested clinically. The objective is to compare the efficacy of SDF gel with that of NaF varnish in preventing carious lesions in preschool children when applied at half-yearly intervals over a 24-month period.

Methods / Design: This non-inferiority randomised clinical trial will recruit 1500 3- to 4-year-old children to receive either SDF gel or NaF varnish every 6 months. The primary outcome is SDF gel will be more effective than NaF varnish in preventing ECC when both are applied at half-yearly intervals at the 24-month follow-up. The same examiner will conduct all examinations at the kindergartens over 24 months. The examiner, the children, and the children's parents will be blinded to treatments. The parents will be surveyed on their child's oral health-related behaviours and socioeconomic background to allow adjustment for effect modification.

Discussion: If the result is as anticipated, clinicians can use SDF gel instead of NaF varnish to prevent ECC. As SDF gel is cost-effective, simple, non-invasive, and non-aerosol generating, it can be widely recommended for prevent early childhood caries. This study will help change the standard of preventive care. If SDF gel is adopted in Hong Kong, it could prevent kindergarten children from developing ECC, thus significantly reducing the burden of ECC among children and the related stress on their families.

Study Type

Interventional

Enrollment (Estimated)

1500

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, China
        • The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • generally healthy, with parental consents

Exclusion Criteria:

  • uncooperative and difficult to manage, have major systemic diseases such as porphyria, or are on long-term medication such as anti-epileptic drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Silver diamine fluoride gel
38% silver diamine fluoride gel
Application of 38% SDF gel every 6 months over 24 months
Other Names:
  • SDF gel
Active Comparator: Sodium Fluoride varnish
5% Sodium Fluoride varnish
Application of 5% NaF varnish every 6 months over 24 months
Other Names:
  • NaF varnish

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caries prevention
Time Frame: The follow-up oral examinations will be conducted every 6 months for 24 months totally
The number of sound tooth surfaces that become cavitated caries per child
The follow-up oral examinations will be conducted every 6 months for 24 months totally

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chun Hung Chu, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2026

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

March 3, 2026

First Submitted That Met QC Criteria

March 3, 2026

First Posted (Actual)

March 6, 2026

Study Record Updates

Last Update Posted (Actual)

March 6, 2026

Last Update Submitted That Met QC Criteria

March 3, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UW 24-828

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Childhood Caries (ECC)

Clinical Trials on Silver diamine fluoride gel

Subscribe